Renovaro biosciences appoints two finance industry experts to board of directors

Los angeles, oct. 10, 2023 (globe newswire) -- renovaro biosciences inc. (nasdaq: renb)(renovaro), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid tumors with short life expectancy, is pleased to announce the appointment of leni boeren and ruud hendriks as independent directors.
RENB Ratings Summary
RENB Quant Ranking